1. Restylane Refyne and Restylane Defyne are dermal fillers injected under the facial skin to reduce the appearance of “laugh lines,” or wrinkles around the edge of the mouth.
2. Synjardy XR is intended to improve blood glucose levels in adults with type 2 diabetes when used alongside diet and exercise.
3. Maci is a tissue repair product that uses patient’s own tissue cells to repair cartilage damage in the knee.
4. Eli Lilly’s diabetes drug Jardiance can now also be used to lower the risk of cardiovascular death in patients with type 2 diabetes mellitus and cardiovascular disease.
5. Euclisa is a topical drug intended to treat mild to moderate cases of eczema.
More articles on supply chain:
7 supply chain lessons from auto and retail industries
FDA approves tissue repair system for knee cartilage injuries: 4 things to know
Eli Lilly offers insulin discount after years of price hikes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
